The Technical AnalystExchange: XETRA Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
MPH Health Care AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.92% €21.20
Europe/Berlin / 2 mai 2024 @ 17:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 90.77 mill |
| EPS: | 11.61 |
| P/E: | 1.830 |
| Earnings Date: | May 30, 2024 |
| SharesOutstanding: | 4.28 mill |
| Avg Daily Volume: | 0.0034 mill |
| RATING 2024-05-02 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 2/23 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | n/a | ||
| Asset | n/a | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.09x |
| Company: PE 1.830 | sector: PE 19.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.05x |
| Company: PE 1.830 | industry: PE 39.15 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€-2.68 (-112.64%) €-23.88 |
| Date: 2024-04-29 |
| Expected Trading Range (DAY) |
|---|
|
€ 20.85 - 22.75 ( +/- 4.36%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | €21.20 (1.92% ) |
| Volume | 0.0019 mill |
| Avg. Vol. | 0.0034 mill |
| % of Avg. Vol | 56.96 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 93M1.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
93M1.DE
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.